2024
Farrington, N., Dubey, V., Johnson, A., Horner, I., Stevenson, A., Unsworth, J., . . . Darlow, C. A. (2024). Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>.. mBio, 15(2), e0316523. doi:10.1128/mbio.03165-23DOI: 10.1128/mbio.03165-23
2023
Hey, S., Haigh, D., Darlow, C., Barrera, M., & Garcia, M. (2023). 26 Fulminant primary EBV infection – Manifestations and complications in a host requiring ECMO. Clinical Infection in Practice, 20, 100291. doi:10.1016/j.clinpr.2023.100291DOI: 10.1016/j.clinpr.2023.100291
Darlow, C. A., Parrott, N., Peck, R. W., & Hope, W. (2023). Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment.. CPT: pharmacometrics & systems pharmacology. doi:10.1002/psp4.13097DOI: 10.1002/psp4.13097
2022
Darlow, C. A., McEntee, L., Johnson, A., Farrington, N., Unsworth, J., Jimenez-Valverde, A., . . . Hope, W. (2022). Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(12), 3349-3357. doi:10.1093/jac/dkac323DOI: 10.1093/jac/dkac323
Darlow, C., Farrington, N., McEntee, L., Johnson, A., Unsworth, J., Jimenez-Valverde, A., . . . Hope, W. (2022). 30 Determining a potential alternative empirical antibiotic regimen for the treatment of neonatal sepsis in low- and middle-income settings using pre-clinical in vitro techniques. Clinical Infection in Practice, 15, 100191. doi:10.1016/j.clinpr.2022.100191DOI: 10.1016/j.clinpr.2022.100191
Darlow, C. A., & Hope, W. (2022). Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales (vol 77, pg 711, 2022). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(7), 2049. doi:10.1093/jac/dkac153DOI: 10.1093/jac/dkac153
Darlow, C. A., & Hope, W. (2022). Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(7), 2047-2048. doi:10.1093/jac/dkac072DOI: 10.1093/jac/dkac072
Darlow, C. (2022, June 6). Determining an Alternate Antimicrobial Regimen for the Empiric Treatment of Neonatal Sepsis in Low- and Middle-Income Countries in the Context of Rising Antimicrobial Resistance.
Darlow, C. A., Farrington, N., Johnson, A., McEntee, L., Unsworth, J., Jimenez-Valverde, A., . . . Hope, W. (2022). Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(5), 1334-1343. doi:10.1093/jac/dkac038DOI: 10.1093/jac/dkac038
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance (Journal article)
Farrington, N., McEntee, L., Johnson, A., Unsworth, J., Darlow, C., Jimenez-Valverde, A., . . . Hope, W. (2022). Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 66(4). doi:10.1128/aac.02181-21DOI: 10.1128/aac.02181-21
2021
Darlow, C. A., & Hope, W. (2021). Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(3), 711-718. doi:10.1093/jac/dkab468DOI: 10.1093/jac/dkab468
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial (vol 68, pg S67, 2019) (Journal article)
Theiss-Nyland, K., Shakya, M., Colin-Jones, R., Voysey, M., Smith, N., Karkey, A., . . . Pollard, A. J. (2021). Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial (vol 68, pg S67, 2019). CLINICAL INFECTIOUS DISEASES, 73(10), 1950. doi:10.1093/cid/ciab802DOI: 10.1093/cid/ciab802
Darlow, C. A., da Costa, R. M. A., Ellis, S., Franceschi, F., Sharland, M., Piddock, L., . . . Hope, W. (2021). Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria. PEDIATRIC DRUGS, 23(5), 465-484. doi:10.1007/s40272-021-00465-zDOI: 10.1007/s40272-021-00465-z
Sadouki, Z., McHugh, T. D., Aarnoutse, R., Canseco, J. O., Darlow, C., Hope, W., . . . Kloprogge, F. (2021). Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76(9), 2252-2259. doi:10.1093/jac/dkab160DOI: 10.1093/jac/dkab160
Darlow, C. A., Docobo-Perez, F., Farrington, N., Johnson, A., McEntee, L., Unsworth, J., . . . Hope, W. (2021). Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.. Antimicrobial Agents and Chemotherapy. doi:10.1128/aac.00293-21DOI: 10.1128/aac.00293-21
2020
Darlow, C. A., McGlashan, N., Kerr, R., Oakley, S., Pretorius, P., Jones, N., & Matthews, P. C. (2020). Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius. JOURNAL OF INFECTION, 80(6), 623-629. doi:10.1016/j.jinf.2020.03.011DOI: 10.1016/j.jinf.2020.03.011
2019
Oguti, B., Gibani, M., Darlow, C., Waddington, C. S., Jin, C., Plested, E., . . . Pollard, A. J. (n.d.). Factors influencing participation in controlled human infection models: a pooled analysis from six enteric fever studies. Wellcome Open Research, 4, 153. doi:10.12688/wellcomeopenres.15469.1DOI: 10.12688/wellcomeopenres.15469.1
Gibani, M. M., Jones, E., Barton, A., Jin, C., Meek, J., Camara, S., . . . Pollard, A. J. (2019). Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model. NATURE MEDICINE, 25(7), 1082-+. doi:10.1038/s41591-019-0505-4DOI: 10.1038/s41591-019-0505-4
2017
Darlow, C. A., Paidakakos, N., Sikander, M., & Atkins, B. (2017). A spinal infection with <i>Staphylococcus pseudintermedius</i>.. BMJ case reports, 2017, bcr-2017-221260. doi:10.1136/bcr-2017-221260DOI: 10.1136/bcr-2017-221260
2013
Darlow, C., Tovey, P., Wallis, F., Knowles, C., Fairley, I., Lacey, C., & Martin, F. (2013). Remembering the Children: Implementation and Success of a Robust Method for Identifying and Testing Children of HIV Patients.. Journal of sexually transmitted diseases, 2013, 828024. doi:10.1155/2013/828024DOI: 10.1155/2013/828024
Remembering the children: Implementation and success of a robust method for the identification and testing of children of HIV-positive parents (Conference Paper)
Darlow, C., Wallis, F., Tovey, P., Knowles, C., Fairley, I., Lacey, C., & Martin, F. (2013). Remembering the children: Implementation and success of a robust method for the identification and testing of children of HIV-positive parents. In HIV MEDICINE Vol. 14 (pp. 32). Retrieved from https://www.webofscience.com/
2011
THE EFFECT OF CORTICOSTEROIDS ON THE T2 APPEARANCE OF GLIOBLASTOMA MULTIFORME (Conference Paper)
Darlow, C. A., Chapman, S., Mohsen, L. A., & Price, S. J. (2011). THE EFFECT OF CORTICOSTEROIDS ON THE T2 APPEARANCE OF GLIOBLASTOMA MULTIFORME. In NEURO-ONCOLOGY Vol. 13 (pp. 3). Retrieved from https://www.webofscience.com/
